Sign In
Get Clay Free →

Suggestions

    Michael Burczynski

    Senior Director, Precision Medicine at Regeneron Pharmaceuticals, Inc.

    Dr. Michael Burczynski, Ph.D., is a renowned biomedical researcher with over two decades of experience leading laboratories and departments in various pharmaceutical companies.

    He is currently a Senior Director within Precision Medicine at Regeneron, overseeing the design and implementation of clinical biomarker studies across diverse therapeutic areas.

    Previously, Dr. Burczynski held key positions at Teva Pharmaceuticals, Bristol Myers Squibb, Roche, and Genetics Institute, contributing to the development of therapies in areas such as migraine, pain, neurodegeneration, and oncology.

    As an adjunct faculty member at the University of Pennsylvania School of Medicine, since 2006, he imparts knowledge in pharmacogenetics and toxicogenomics.

    Apart from his significant contributions to the field of biomedicine, Dr. Burczynski is also a successful novelist writing under the pen name Michael Ransom, known for his award-winning debut novel, The Ripper Gene.

    He is an active member of reputable writing organizations like the Mystery Writers of America, International Thriller Writers, and the Author's Guild, frequently engaging in literary events in the NYC area.

    With more than fifty peer-reviewed scientific articles, invited reviews, book chapters, and editing credits to his name, Dr. Burczynski continues to make a profound impact in both the scientific and literary realms.

    Michael Burczynski
    Add to my network

    Location

    Butler, New Jersey, United States